| CYHS2201997 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2022-11-17 | | Ningbo Menovo TianKang Pharmaceutical Co Ltd | | | view |
| CXHL1501425 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2016-01-05 | 江西施美制药有限公司 | Jiangxi Shimei Pharmaceutical Co Ltd | Certificate Issued | 2016-11-23 | view |
| CXHL1500237 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-03-19 | 山东罗欣药业集团股份有限公司 | Shandong Luoxin Pharmaceutical Group STOCK Co Ltd | Certificate Issued | 2016-05-31 | view |
| CYHS2201869 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2022-11-01 | | QILU Pharmaceutical Co Ltd | | | view |
| CXHL1401131 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-08-20 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2016-03-10 | view |
| CYHS2000307 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2020-05-06 | 北京福元医药股份有限公司 | Beijing Foyou Pharma Co Ltd | Certificate Issued | 2021-11-02 | view |
| JYHB1801041 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2018-08-31 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-09-05 | view |
| JYHB1700827 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-06-08 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-10-20 | view |
| CYHS2200642 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2022-04-25 | | | | | view |
| JXHL1500156 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-23 | view |
| CYHS2301517 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2023-06-03 | | Hunan Jiudian Pharmaceutical Co Ltd | | | view |
| JYHZ2100521 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | License Renew | 2021-04-19 | | | | | view |
| CXHL1401404 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-10-16 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-03-25 | view |
| JYHB2100083 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2021-01-21 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2021-01-28 | view |
| JYHB1900693 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-06-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2019-06-07 | view |
| CYHS2300929 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2023-03-30 | | Shijiazhuang NO4 Pharmaceutical Co Ltd | | | view |
| JXHL0800042 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(1.1) | Import Drug Application | 2008-01-29 | | Bristol-Myers Squibb Company | Certificate Issued | 2008-12-02 | view |
| JYHB1900717 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-06-22 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-16 | view |
| JYHB1701015 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-08-08 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-11-19 | view |
| JXHS1500112 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-12-16 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-20 | view |
